Does ESCITALOPRAM OXALATE Cause Bladder transitional cell carcinoma? 6 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Bladder transitional cell carcinoma have been filed in association with ESCITALOPRAM OXALATE (Escitalopram). This represents 0.0% of all adverse event reports for ESCITALOPRAM OXALATE.
6
Reports of Bladder transitional cell carcinoma with ESCITALOPRAM OXALATE
0.0%
of all ESCITALOPRAM OXALATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From ESCITALOPRAM OXALATE?
Of the 6 reports.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESCITALOPRAM OXALATE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ESCITALOPRAM OXALATE Cause?
Drug ineffective (2,792)
Anxiety (1,686)
Headache (1,643)
Somnolence (1,640)
Nausea (1,635)
Completed suicide (1,504)
Drug interaction (1,477)
Toxicity to various agents (1,446)
Fatigue (1,443)
Off label use (1,422)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which ESCITALOPRAM OXALATE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
ESCITALOPRAM OXALATE vs ESKETAMINE
ESCITALOPRAM OXALATE vs ESLICARBAZEPINE
ESCITALOPRAM OXALATE vs ESMOLOL
ESCITALOPRAM OXALATE vs ESOMEPRAZOLE
ESCITALOPRAM OXALATE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE